Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction
This study addresses the issues in translating the laboratory derived data obtained during discovery phase of research to a clinical setting using a breast cancer model. Laboratory-based risk assessment indi-cated that a family history of breast cancer, reduced folate carrier 1 (RFC1) G80A, thymidyl...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Deccan College of Medical Sciences
2011-01-01
|
Series: | Journal of Medical and Allied Sciences |
Subjects: | |
Online Access: | http://www.jmas.in/To%20Tripresh/Clinical%20utility%20of%20polymorphisms%20in%20one-carbon%20metabolism%20for%20breast%20cancer%20risk%20prediction.pdf |
id |
doaj-e159b41919ea4143a1d643b57a293132 |
---|---|
record_format |
Article |
spelling |
doaj-e159b41919ea4143a1d643b57a2931322020-11-24T22:46:50ZengDeccan College of Medical SciencesJournal of Medical and Allied Sciences2231-16962231-170X2011-01-0111713Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk predictionShaik Mohammad NaushadVijay Kumar KutalaSuryanarayana Raju GottumukkalaRaghunadha Rao DigumartiYedluri RupasreeShree DivyyaAddepalli PavaniThis study addresses the issues in translating the laboratory derived data obtained during discovery phase of research to a clinical setting using a breast cancer model. Laboratory-based risk assessment indi-cated that a family history of breast cancer, reduced folate carrier 1 (RFC1) G80A, thymidylate synthase (TYMS) 5’-UTR 28bp tandem repeat, methylene tetrahydrofolate reductase (MTHFR) C677T and catecholamine-O-methyl transferase (COMT) genetic polymorphisms in one-carbon metabolic pathway increase the risk for breast cancer. Glutamate carboxypeptidase II (GCPII) C1561T and cytosolic serine hydroxymethyl transferase (cSHMT) C1420T polymorphisms were found to decrease breast cancer risk. In order to test the clinical validity of this information in the risk prediction of breast cancer, data was stratified based on number of protective alleles into four categories and in each category sensitivity and 1-specificity values were obtained based on the distribution of number of risk alleles in cases and controls. Receiver operating characteristic (ROC) curves were plotted and the area under ROC curve (C) was used as a measure of discriminatory ability between cases and controls. In subjects without any protective allele, aberrations in one-carbon metabolism showed perfect prediction (C=0.93) while the predictability was lost in subjects with one protective allele (C=0.60). However, predictability increased steadily with increasing number of protective alleles (C=0.63 for 2 protective alleles and C=0.71 for 3 protective alleles). The cut-off point for discrimination was >4 alleles in all predictable combinations. Models of this kind can serve as valuable tools in translational re-search, especially in identifying high-risk individuals and reducing the disease risk either by life style modification or by medical intervention.http://www.jmas.in/To%20Tripresh/Clinical%20utility%20of%20polymorphisms%20in%20one-carbon%20metabolism%20for%20breast%20cancer%20risk%20prediction.pdfBreast cancerone-carbon metabolismpolymorphismodds ratiosreceiver operating characteristic (ROC) curverisk prediction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shaik Mohammad Naushad Vijay Kumar Kutala Suryanarayana Raju Gottumukkala Raghunadha Rao Digumarti Yedluri Rupasree Shree Divyya Addepalli Pavani |
spellingShingle |
Shaik Mohammad Naushad Vijay Kumar Kutala Suryanarayana Raju Gottumukkala Raghunadha Rao Digumarti Yedluri Rupasree Shree Divyya Addepalli Pavani Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction Journal of Medical and Allied Sciences Breast cancer one-carbon metabolism polymorphism odds ratios receiver operating characteristic (ROC) curve risk prediction |
author_facet |
Shaik Mohammad Naushad Vijay Kumar Kutala Suryanarayana Raju Gottumukkala Raghunadha Rao Digumarti Yedluri Rupasree Shree Divyya Addepalli Pavani |
author_sort |
Shaik Mohammad Naushad |
title |
Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction |
title_short |
Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction |
title_full |
Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction |
title_fullStr |
Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction |
title_full_unstemmed |
Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction |
title_sort |
clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction |
publisher |
Deccan College of Medical Sciences |
series |
Journal of Medical and Allied Sciences |
issn |
2231-1696 2231-170X |
publishDate |
2011-01-01 |
description |
This study addresses the issues in translating the laboratory derived data obtained during discovery phase of research to a clinical setting using a breast cancer model. Laboratory-based risk assessment indi-cated that a family history of breast cancer, reduced folate carrier 1 (RFC1) G80A, thymidylate synthase (TYMS) 5’-UTR 28bp tandem repeat, methylene tetrahydrofolate reductase (MTHFR) C677T and catecholamine-O-methyl transferase (COMT) genetic polymorphisms in one-carbon metabolic pathway increase the risk for breast cancer. Glutamate carboxypeptidase II (GCPII) C1561T and cytosolic serine hydroxymethyl transferase (cSHMT) C1420T polymorphisms were found to decrease breast cancer risk. In order to test the clinical validity of this information in the risk prediction of breast cancer, data was stratified based on number of protective alleles into four categories and in each category sensitivity and 1-specificity values were obtained based on the distribution of number of risk alleles in cases and controls. Receiver operating characteristic (ROC) curves were plotted and the area under ROC curve (C) was used as a measure of discriminatory ability between cases and controls. In subjects without any protective allele, aberrations in one-carbon metabolism showed perfect prediction (C=0.93) while the predictability was lost in subjects with one protective allele (C=0.60). However, predictability increased steadily with increasing number of protective alleles (C=0.63 for 2 protective alleles and C=0.71 for 3 protective alleles). The cut-off point for discrimination was >4 alleles in all predictable combinations. Models of this kind can serve as valuable tools in translational re-search, especially in identifying high-risk individuals and reducing the disease risk either by life style modification or by medical intervention. |
topic |
Breast cancer one-carbon metabolism polymorphism odds ratios receiver operating characteristic (ROC) curve risk prediction |
url |
http://www.jmas.in/To%20Tripresh/Clinical%20utility%20of%20polymorphisms%20in%20one-carbon%20metabolism%20for%20breast%20cancer%20risk%20prediction.pdf |
work_keys_str_mv |
AT shaikmohammadnaushad clinicalutilityofpolymorphismsinonecarbonmetabolismforbreastcancerriskprediction AT vijaykumarkutala clinicalutilityofpolymorphismsinonecarbonmetabolismforbreastcancerriskprediction AT suryanarayanarajugottumukkala clinicalutilityofpolymorphismsinonecarbonmetabolismforbreastcancerriskprediction AT raghunadharaodigumarti clinicalutilityofpolymorphismsinonecarbonmetabolismforbreastcancerriskprediction AT yedlurirupasree clinicalutilityofpolymorphismsinonecarbonmetabolismforbreastcancerriskprediction AT shreedivyya clinicalutilityofpolymorphismsinonecarbonmetabolismforbreastcancerriskprediction AT addepallipavani clinicalutilityofpolymorphismsinonecarbonmetabolismforbreastcancerriskprediction |
_version_ |
1725683601481138176 |